Abstract
Purpose
Borderline ovarian tumors (BOTs) constitute about a quarter of epithelial ovarian malignancies and require different treatment approaches. The present study aims to document the experience of a single center on the treatment outcome of women who had conservative or comprehensive surgery for BOTs.
Methods
One hundred eighty-three patients with BOTs, diagnosed and/or treated in our center between January of 2000 and March of 2013, were reviewed retrospectively.
Results
The mean age at diagnosis was 40.6 years old (range 17–78). Ninety-five patients (51 %) were ≤40 years. Comprehensive surgical staging and fertility sparing surgery were performed in 49 % (n = 91) and 48 % of patients (n = 89) respectively. A hundred and forty-seven patients had stage IA disease (80 %). The most common type of BOT was serous in histology with 18 % bilateralism. CA-125 and CA-199 levels were increased in 29 (19 %) and 15 (10 %) patients with stage IA disease. Non-invasive tumor implants were diagnosed in 9 patients (4 %) and uterine involvement was 2 % among BOT patients that underwent hysterectomies. The mean post-operative follow-up period was 20.4 months (range 6–78 months). Disease recurrence was seen in 5 patients indicating overall recurrence rate of 2.7 %.
Conclusions
In our study, we evaluated a large data pool of 183 patients diagnosed with borderline epithelial ovarian tumors. BOTs have a relatively better prognosis than invasive epithelial ovarian cancer. Surgery with proper staging is the cornerstone of treatment. Patients with BOTs at the early stage can undergo fertility sparing surgery with close follow-up.
Similar content being viewed by others
References
Seidman JD, Soslow RA, Vang R, Berman JJ, Stoler MH, Sherman ME, Oliva E, Kajdacsy-Balla A, Berman DM, Copeland LJ (2004) Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol 35(8):918–933
Trope CG, Kaern J, Davidson B (2012) Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol 26(3):325–336. doi:10.1016/j.bpobgyn.2011.12.006
Ayhan A, Guvendag Guven ES, Guven S, Kucukali T (2005) Recurrence and prognostic factors in borderline ovarian tumors. Gynecol Oncol 98(3):439–445. doi:10.1016/j.ygyno.2005.05.033
Poncelet C, Fauvet R, Yazbeck C, Coutant C, Darai E (2010) Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: multivariate analysis of a French multicentre study. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 36(11):1066–1072. doi:10.1016/j.ejso.2010.07.004
Menczer J, Chetrit A, Sadetzki S (2012) The effect of hysterectomy on survival of patients with borderline ovarian tumors. Gynecol Oncol 125(2):372–375. doi:10.1016/j.ygyno.2012.02.017
Kanat-Pektas M, Ozat M, Gungor T, Sahin I, Yalcin H, Ozdal B (2011) Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors? Arch Gynecol Obstet 283(4):879–884. doi:10.1007/s00404-010-1539-5
Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A (2006) Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol 100(1):185–191. doi:10.1016/j.ygyno.2005.09.021
Yinon Y, Beiner ME, Gotlieb WH, Korach Y, Perri T, Ben-Baruch G (2007) Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors. Fertil Steril 88(2):479–484. doi:10.1016/j.fertnstert.2006.11.128
Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH (2009) Surgical management of borderline ovarian tumors: the role of fertility-sparing surgery. Gynecol Oncol 113(1):75–82. doi:10.1016/j.ygyno.2008.12.034
Wu TI, Lee CL, Wu MY, Hsueh S, Huang KG, Yeh CJ, Lai CH (2009) Prognostic factors predicting recurrence in borderline ovarian tumors. Gynecol Oncol 114(2):237–241. doi:10.1016/j.ygyno.2009.05.018
Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E (2012) Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol 13(3):e103–e115. doi:10.1016/S1470-2045(11)70288-1
Gotlieb WH, Chetrit A, Menczer J, Hirsh-Yechezkel G, Lubin F, Friedman E, Modan B, Ben-Baruch G (2005) Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 97(3):780–783. doi:10.1016/j.ygyno.2005.02.022
Romagnolo C, Gadducci A, Sartori E, Zola P, Maggino T (2006) Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol 101(2):255–260. doi:10.1016/j.ygyno.2005.10.014
Messalli EM, Grauso F, Balbi G, Napolitano A, Seguino E, Torella M (2013) Borderline ovarian tumors: features and controversial aspects. Eur J Obstet Gynecol Reprod Biol 167(1):86–89. doi:10.1016/j.ejogrb.2012.11.002
McCluggage WG (2010) The pathology of and controversial aspects of ovarian borderline tumours. Curr Opin Oncol 22(5):462–472. doi:10.1097/CCO.0b013e32833b0dc1
Avril S, Hahn E, Specht K, Hauptmann S, Hoss C, Kiechle M, Hofler H, Schmalfeldt B (2012) Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome. Gynecol Oncol 127(3):516–524. doi:10.1016/j.ygyno.2012.08.027
Park JY, Kim DY, Kim JH, Kim YM, Kim KR, Kim YT, Nam JH (2011) Micropapillary pattern in serous borderline ovarian tumors: does it matter? Gynecol Oncol 123(3):511–516. doi:10.1016/j.ygyno.2011.08.008
Acs G (2005) Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 123(Suppl):S13–S57
Lesieur B, Kane A, Duvillard P, Gouy S, Pautier P, Lhomme C, Morice P, Uzan C (2011) Prognostic value of lymph node involvement in ovarian serous borderline tumors. Am J Obstet Gynecol 204(5):438 e1–438 e7. doi:10.1016/j.ajog.2010.12.055
Tinelli R, Malzoni M, Cosentino F, Perone C, Tinelli A, Malvasi A, Cicinelli E (2009) Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors. Fertil Steril 92(2):736–741. doi:10.1016/j.fertnstert.2008.07.1716
du Bois A, Ewald-Riegler N, de Gregorio N, Reuss A, Mahner S, Fotopoulou C, Kommoss F, Schmalfeldt B, Hilpert F, Fehm T, Burges A, Meier W, Hillemanns P, Hanker L, Hasenburg A, Strauss HG, Hellriegel M, Wimberger P, Keyver-Paik MD, Baumann K, Canzler U, Wollschlaeger K, Forner D, Pfisterer J, Schroder W, Munstedt K, Richter B, Kommoss S, Hauptmann S, Arbeitsgmeinschaft Gynakologische Onkologie Study G (2013) Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynakologische Onkologie (AGO) Study Group. Eur J Cancer 49(8):1905–1914. doi:10.1016/j.ejca.2013.01.035
Nam JH (2010) Borderline ovarian tumors and fertility. Curr Opin Obstet Gynecol 22(3):227–234. doi:10.1097/GCO.0b013e3283384928
Kanat-Pektas M, Ozat M, Gungor T, Dikici T, Yilmaz B, Mollamahmutoglu L (2011) Fertility outcome after conservative surgery for borderline ovarian tumors: a single center experience. Arch Gynecol Obstet 284(5):1253–1258. doi:10.1007/s00404-010-1804-7
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gungor, T., Cetinkaya, N., Yalcin, H. et al. Retrospective evaluation of borderline ovarian tumors: single center experience of 183 cases. Arch Gynecol Obstet 291, 123–130 (2015). https://doi.org/10.1007/s00404-014-3381-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-014-3381-7